February - 2020

Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4

The ALS4 team, Christopher Grunseich, MD, and Vivian G. Cheung, MD, with the National Institutes of Health recently published the...

NIH Research: March 2014

Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4

Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in

Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene Pro

Beyond DNA: March 2016

Discovery Medicine: February 2015

Genes and Development: April 2014

NIH Research: March 2014

PLOS: November 2013

Genes & Development: October 2013

Identification of the ALS4 Gene Mutation: June 2004

ALS4